Category: News & Articles
... week, with a project aimed at developing a new targeted treatment for acute myeloid leukaemia. HMRI researcher Dr Kathryn Skelding is one of 17 young ... is also collaborating with colleague Dr Nikki Verrills on an acute lymphoblastic leukaemia project, studying a new mechanism for ...
Category: Research
Leukaemia is a cancer of the blood or bone marrow involving abnormal ... every year. (Source – Australian Institute of Health and Welfare ) Acute Lymphoblastic Leukaemia (ALL) is one of the most deadly and most common ...
Category: News & Articles
... Dr Matt Dun has revealed a more targeted way of treating T-cell acute lymphoblastic leukaemia (T-ALL), an aggressive cancer prevalent in children. Research ...
Category: Research
Research Identification of novel markers in paediatric acute lymphoblastic leukaemia; investigation of DNA methylations and non-coding small ...
Category: News & Articles
... conducted by HMRI into the most common type of childhood cancer, Acute Lymphoblastic Leukaemia (A.L.L). Geary, proprietor of the Good Guys Kotara, his ...
Category: Researcher Profiles
... but do not affect normal healthy cells. My work is applicable to all cancer types, but I focus primarily on two diseases: Acute myeloid leukaemia (AML) – the most common adult leukaemia, with a dismal 5year ...
Category: Research
... is the most common cause of childhood disease-related deaths, with leukaemia the most common childhood cancer in Australia. The two most common forms of leukaemia in children are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Whilst ...
Category: News & Articles
... Awarded to Dr Andrew Ziolkowski | An A(r)Ray of hope for paediatric Acute Lymphoblastic Leukaema – improving risk stratification and outcome. ... on kidney function for infants in the Gomeroi gaaynggal cohort. HMRI Leukaemia Project Grant Awarded to Dr Danielle Bond | How does the bone ...
Category: News & Articles
... and cellular aging. This study will test this hypothesis of both acute and chronic stress to provide an explanation of stress-induced ... PP2A as a Novel Therapeutic Strategy for mutant FLT3+ Acute Myeloid Leukaemia Recent advancements in medical research have led to remarkable ... of PP2A activating compounds for the treatment of childhood acute lymphoblastic leukaemia This project will show for the first time, the ...
Category: News & Articles
... as biomarker and unique target for anti-cancer therapy in paediatric acute lymphoblastic leukaemia Researchers have identified a unique marker ...
